Treatment free remission in pediatric chronic myeloid leukemia

Treatment free remission in pediatric chronic myeloid leukemia

Background: The aim was to evaluate the impact of discontinuation of imatinib in children in chronic phase of chronic myeloid leukemia (CML) and assess treatment free remission (TFR). Patients and methods: We performed a retrospective study in children diagnosed with CML chronic phase up to 18 years...

Full description

Bibliographic Details
Main Authors: Meena Satishkumar, Vellaichamy Swaminathan Venkateswaran, Ganesan Kavitha, Duraisamy Suresh, Chakraborty Sohini, Uppuluri Ramya, Raj Revathi
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Pediatric Hematology Oncology Journal
Subjects:
CML
Treatment free remission
Imatinib
Children
Long-term outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2468124523000013

Internet

http://www.sciencedirect.com/science/article/pii/S2468124523000013

Similar Items